Correlation Between Sinphar Pharmaceutical and StShine Optical

Can any of the company-specific risk be diversified away by investing in both Sinphar Pharmaceutical and StShine Optical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sinphar Pharmaceutical and StShine Optical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sinphar Pharmaceutical Co and StShine Optical Co, you can compare the effects of market volatilities on Sinphar Pharmaceutical and StShine Optical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sinphar Pharmaceutical with a short position of StShine Optical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sinphar Pharmaceutical and StShine Optical.

Diversification Opportunities for Sinphar Pharmaceutical and StShine Optical

-0.26

Correlation Coefficient

Sinphar Pharmaceutical  StShine Optical

Very good diversification

The 3 months correlation between Sinphar and StShine is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Sinphar Pharmaceutical Co and StShine Optical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on StShine Optical and Sinphar Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sinphar Pharmaceutical Co are associated (or correlated) with StShine Optical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of StShine Optical has no effect on the direction of Sinphar Pharmaceutical i.e., Sinphar Pharmaceutical and StShine Optical go up and down completely randomly.

Pair Corralation between Sinphar Pharmaceutical and StShine Optical

Assuming the 90 days trading horizon Sinphar Pharmaceutical Co is expected to under-perform the StShine Optical. But the stock apears to be less risky and, when comparing its historical volatility, Sinphar Pharmaceutical Co is 3.22 times less risky than StShine Optical. The stock trades about -0.21 of its potential returns per unit of risk. The StShine Optical Co is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  17,850  in StShine Optical Co on September 26, 2024 and sell it today you would earn a total of  1,800  from holding StShine Optical Co or generate 10.08% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.44%
Values	Daily Returns

Sinphar Pharmaceutical Co  vs.  StShine Optical Co

Sinphar Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sinphar Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

StShine Optical

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in StShine Optical Co are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, StShine Optical may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Sinphar Pharmaceutical and StShine Optical

The main advantage of trading using opposite Sinphar Pharmaceutical and StShine Optical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sinphar Pharmaceutical position performs unexpectedly, StShine Optical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in StShine Optical will offset losses from the drop in StShine Optical's long position.

The idea behind Sinphar Pharmaceutical Co and StShine Optical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.